Mirae Asset Healthcare Fund · Direct · Growth
NAV
₹55.0050
as of 17 Nov 2026
Expense Ratio
0.59%
Lumpsum returns (CAGR)
- 1Y
- +26.08%
- 3Y
- +23.55%
- 5Y
- +17.68%
- Since Inception
- +22.57%
SIP returns (XIRR)
- 1Y
- +36.54%
- 3Y
- +21.41%
- 5Y
- +22.38%
- Since Inception
- +22.98%
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology75.86%
- Healthcare Services20.53%
- Chemicals & Petrochemicals1.80%
- Healthcare Equipment & Supplies1.69%
Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Mirae Asset Healthcare Fund - Regular Plan - Growth
- 1Sun Pharmaceutical Industries Ltd.10.32%
- 2Divi'S Laboratories Ltd.9.97%
- 3Torrent Pharmaceuticals Ltd.6.41%
- 4Laurus Labs Ltd.6.37%
- 5Apollo Hospitals Enterprise Ltd.5.81%
- 6Dr. Reddy'S Laboratories Ltd.5.45%
- 7Glenmark Pharmaceuticals Ltd.4.61%
- 8Aurobindo Pharma Ltd.3.73%
- 9Alkem Laboratories Ltd.3.65%
- 10Krishna Institute Of Medical Sciences Ltd.3.48%
What this fund does
Mirae Asset Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 8 years. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 0.59%.